Non-clinical safety assessment of single and repeated administration of gE/AS01 zoster vaccine in rabbits.

about

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans.

P2860

Q40064119-D806CF5E-1CCB-497D-B13C-F5D09BD01A5E

P2860

Non-clinical safety assessment of single and repeated administration of gE/AS01 zoster vaccine in rabbits.

Item

http://www.wikidata.org/entity/Q40757793

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Non-clinical safety assessment ...... S01 zoster vaccine in rabbits.

@en

type

Item

label

Non-clinical safety assessment ...... S01 zoster vaccine in rabbits.

@en

prefLabel

Non-clinical safety assessment ...... S01 zoster vaccine in rabbits.

@en

P1476

Non-clinical safety assessment ...... AS01 zoster vaccine in rabbits

@en

P2093

Eric Destexhe

http://www.w3.org/2001/XMLSchema#string

Giulia Giordano

http://www.w3.org/2001/XMLSchema#string

Marcel V W Wijnands

http://www.w3.org/2001/XMLSchema#string

Menk Prinsen

http://www.w3.org/2001/XMLSchema#string

Nathalie Garçon

http://www.w3.org/2001/XMLSchema#string

P2860

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection

Neurologic complications of the reactivation of varicella-zoster virus.

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives.

Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection

Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents.

Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant.

Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su): a phase-I, open-label study in Japanese adults.

Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.

Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking.

P304

132-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JAT.3329

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

L Segal

P577

2016-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27172098

http://www.w3.org/2001/XMLSchema#string

Non-clinical safety assessment of single and repeated administration of gE/AS01 zoster vaccine in rabbits.

about

P2860

P2860

Non-clinical safety assessment of single and repeated administration of gE/AS01 zoster vaccine in rabbits.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698